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Abstract 
Purpose: This study assesses the construct validity and sensitivity to change of the Short Warwick‑Edinburgh Mental 
Well‑being Scale (SWEMWBS) as an outcome measure in the treatment of common mental disorders (CMD) in pri‑
mary care settings.
Methods: 127 participants attending up to 5 sessions of therapy for CMD in primary care self‑rated the SWEMWBS, 
the Patient Health Questionnaire (PHQ‑9) and General Anxiety Disorder (GAD‑7) scales. SWEMWBS’s construct validity 
and sensitivity to change was evaluated against the PHQ‑9 and GAD‑7 across multiple time points in two ways: corre‑
lation coefficients were calculated between the measures at each time point; and sensitivity to change over time was 
assessed using repeated measures ANOVA.
Results: Score distributions on SWEMWBS, but not PHQ‑9 and GAD‑7, met criteria for normality. At baseline, 92.9% 
(118/127) of participants scored above clinical threshold on either PHQ‑9 or GAD‑7. Correlations between SWEM‑
WBS and PHQ‑9 scores were calculated at each respective time point and ranged from 0.601 to 0.793. Correlations 
between SWEMWBS and GAD‑7 scores were calculated similarly and ranged from 0.630 to 0.743. Significant improve‑
ments were seen on all three scales over time. Changes in PHQ‑9 and GAD‑7 were curvilinear with greatest improve‑
ment between sessions 1 and 2. Change in SWEMWBS was linear over the five sessions.
Conclusions: This exploratory study suggests that SWEMWBS is acceptable as a CMD outcome measure in primary 
care settings, both in terms of construct validity and sensitivity to change. Given patient preference for positively over 
negatively framed measures and statistical advantages of measures which are normally distributed, SWEMWBS could 
be used as an alternative to PHQ‑9 and GAD‑7 in monitoring and evaluating CMD treatment.
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Introduction
The Warwick-Edinburgh Mental Well-Being Scale 
(WEMWBS) was developed in 2007 [1] to support the 
emerging discipline of public mental health [2] by ena-
bling monitoring of positive mental health and evalu-
ation of interventions, programmes and approaches to 
promoting mental health particularly in non-clinical 
populations. Development involved qualitative research 
with members of the general public and mental health 
service users regarding the nature of mental wellbeing as 
well as the face validity of the scale [1]. In 2009, a seven 
item version of the original 14 item scale, the Short War-
wick–Edinburgh Mental Well-Being Scale (SWEMWBS), 
was developed using Rasch modelling to provide better 
fit as an interval scale measure of mental wellbeing [3]. 
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The SWEMWBS also has the added benefit of being 
shorter and thus less onerous to complete.
The concept of mental wellbeing was developed in the 
context of positive psychology [4]. It is now recognised 
as a core indicator of overall health in some jurisdictions 
[5] and some countries now use (S)WEMWBS as an indi-
cator in this context [6–10]. The concept has proved of 
interest in both mental health services and primary care, 
where it has been linked to patient-centred and recovery 
agendas [11–15]. The best approach to measurement of 
mental wellbeing has been widely debated, but consensus 
is growing to support the conceptual framework within 
which WEMWBS was developed, in which mental well-
being covers aspects of both feeling good (Hedonia) and 
functioning well (Eudaimonia) [16, 17]. The SWEMWBS 
also covers both concepts although has fewer items relat-
ing to feeling good than functioning well [3]. Some have 
proposed a ‘dual continuum’ model in which mental ill-
ness and mental wellbeing represent different dimensions 
and thus should be measured separately [18], whereas 
others perceive mental wellbeing and mental ill-health to 
represent extremes of a single underlying factor. Whilst 
there is no consensus on single/dual continuum hypoth-
eses, studies to date show a high degree of (inverse) 
correlation between WEMWBS and widely respected 
measures of mental illness [1, 19].
Common mental health disorders (CMDs) comprise 
of depression, anxiety, panic attacks, and obsessive com-
pulsive disorders and are highly prevalent being experi-
enced by 14.7% of men and 23.1% of women in the UK 
according to 2014 estimates [20]. CMDs affect people’s 
ability to work, care for others and participate in soci-
ety. Lost productivity as a result of two of the most com-
mon mental disorders, anxiety and depression costs the 
global economy US$ 1 trillion each year [21]. Only 39% of 
people with CMD in the UK report accessing treatment 
[20], meaning there is a need to explore the effectiveness 
of non-specialist mental health interventions in com-
munity, primary care, and public health settings for this 
group as well as increasing access to clinical interven-
tion. The recent COVID pandemic has been associated 
with increases in estimated prevalence of CMD, and the 
longer term impacts of this are yet to be seen [22].
Qualitative studies have indicated that mental health 
service users and their carers would choose WEMWBS 
over other commonly used measures for monitoring and 
evaluating the effect of interventions on their mental 
health [23]. WEMWBS scored higher on appropriateness 
rating scales than the PHQ-9 [24] with users highlight-
ing a preference for scales that are positively framed and 
reflect the judgements and interests of service users over 
those of professionals [23]. As a result the scales are now 
being used in NHS and private health services often in 
conjunction with other measures of mental illness such as 
the PHQ-9 and GAD-7, and the CORE Outcome Meas-
ure [25, 26]. It has become important to investigate the 
validity of both WEMWBS and SWEMWBS for use as 
outcome and monitoring measures in people with CMD 
to address the burden of CMD in more appropriate ways 
and to allow comparison of approaches across settings. 
Studies in different settings suggest these measures are 
valid in psychiatric populations [13, 27, 28] and primary 
care [29], but comparative performance in relation to 
commonly used clinical measures at multiple time points 
during a course of treatment has not been investigated.
The aim of this study was to investigate the construct 
validity of SWEMWBS as an outcome measure in 
patients with CMD undergoing psychological therapy in 
comparison to two widely used primary care based clini-
cal outcome measures, the Patient Health Questionnaire 




The data for this study were gathered using electronic 
software developed by the Pragmatic Research Network, 
a collaboration of professionals promoting service-based 
evaluation and feedback-informed treatment. The soft-
ware allows session by session administration of outcome 
measures, producing reports for feedback to clients and 
therapists to inform the progress of the therapy and ser-
vice evaluation.
Data were collected by therapists practicing a form of 
psychotherapy, cognitive hypnotherapy (CHT). Thera-
pists were informed about the proposed study through an 
online forum and invited to participate in the research. 
Fully anonymised data from consented participants and 
therapists was made available for the study. The Prag-
matic Research Network supervised data collection for 
those who consented to take part, providing an initial 
training day and a combination of face-to-face, telephone 
and e-mail support to ensure an appropriate standard 
was reached.
CHT uses induction into a trance-like state to access 
unconscious problematic thoughts, feelings, and memory 
patterns. Therapy focuses on interrupting faulty pattern 
matching by changing the context, structure, process 
or consequence of the problem pattern and is individu-
ally tailored to clients’ needs [32]. It starts with an initial 
session which seeks to introduce the client to hypnosis, 
uncover the language clients use and identify the uncon-
scious phenomena they experience whilst acting within 
unconscious patterns. As such the therapeutic process 
begins during the first session. The three measures were 
administered before each therapeutic session including 
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the first and discussed within the sessions to provide 
feedback and inform progress. The length and frequency 
of subsequent treatment is negotiated between therapist 
and client based upon progress, ongoing need, and will-
ingness to pay. A low number of sessions may indicate 
early success of treatment, termination due to perceived 
ineffectiveness or not liking the process, or limited will-
ingness to pay for the therapy [32].
Participants
Participants were adults seeking CHT as treatment for 
mental health problems, mainly anxiety and depression, 
at the private, fee paying practices of participating thera-
pists between October 2014 and April 2016. All partici-
pants were informed about the research objectives and 
written consent was obtained. 127 participants were 
recruited and provided data at the first session (Therapy 
1) and at least one more session, enabling measurement 
of change over time; 34 participants provided data for 
five consecutive sessions.
Measures
Participants completed three measures for the first time 
before Therapy 1 and each subsequent treatment session. 
Measures were given to participants to complete using 
the web based ‘pragmatic tracker’ software either via 
email link or on arrival to their session. The three meas-
ures were the SWEMWBS [3]; PHQ-9 [24] and GAD-7 
[31]. Both GAD-7 and PHQ-9 are measures of CMD 
developed for evaluation of the UK Increasing Access to 
Psychological Therapy programme [33] and now widely 
used in primary care.
SWEMWBS is a seven item self-report measure of 
mental wellbeing [3]. Construct validity has been con-
firmed in diverse populations [3, 10, 28, 34–36] using 
methods such as confirmatory factor analysis and Rasch 
modelling, alongside assessment of external validity in 
comparison to other scales and content validity. Test–
retest reliability has been confirmed in other popula-
tions [37]. SWEMWBS is responsive to change at group 
(standard response mean (SRM) ranged from 0.49 to 1.01 
and probability of change statistic from 0.65 to 0.88) and 
individual level (at the threshold 2.77 standard errors 
of the mean (SEM) SWEMWBS demonstrated change 
in 20.1–80.6% of participants) [38]. The England popu-
lation mean for SWEMWBS is (23.6) and cut points of 
one standard deviation above (28.1) and below (19.3) the 
mean have been used to derive normal, low and high lev-
els of mental wellbeing respectively [35]. SWEMWBS has 
been translated into various languages [39].
PHQ-9 is a self-administered version of Primary Care 
Evaluation of Mental Disorders (PRIME-MD), an instru-
ment developed to assist primary care clinicians in 
making criteria-based diagnoses of five types of Diagnos-
tic and Statistical Manual of Mental Disorders,  4th edition 
(DSM-IV) disorders, mood, anxiety, somatoform, alco-
hol, and eating (the current manual at time of develop-
ment). The nine item PHQ-9 is the depression module of 
the full PHQ and consists of the nine criteria on which 
the diagnosis of DSM-IV depressive disorders is based 
[40]. PHQ-9 scores of greater than or equal to 5, 10, 15, 
and 20 out of 27 represent mild, moderate, moderately 
severe, and severe depression, respectively. PHQ-9 has 
been widely used as a diagnostic tool as well as a measure 
of depression severity, and has been shown to be respon-
sive to change with a minimum clinically important dif-
ference of 5 points based upon a difference of 2 standard 
errors of the mean (SEM) in a clinical sample [30, 41].
The GAD-7 is a self-rated tool for screening for gener-
alised anxiety disorder (GAD) and assessing its severity in 
clinical practice and research. Initial items were based on 
DSM-IV diagnostic symptom criteria for GAD and exist-
ing anxiety scales. The seven item anxiety scale (GAD-7) 
has been shown to have good reliability as well as crite-
rion, construct and factorial validity when administered 
in primary care settings [31]. Cut off scores of greater 
than or equal to 5, 10, and 15 out of 21 represent mild, 
moderate and severe anxiety respectively, and a clinical 
cut off score of 10 has been identified as indicating prob-
able diagnosis of GAD, social phobia, panic disorder, and 
posttraumatic stress disorder based on receiver operator 
curve (ROC) analyses. When used in a clinical sample the 
scale demonstrates ability to detect change with a moder-
ate pre-post treatment effect size (Cohen’s D) of 0.78 [42].
Statistical analysis
Analyses were performed using SPSS 24.0. Score distri-
butions for each scale were assessed by visual inspec-
tion and the Shapiro–Wilk test for normality. Mean and 
standard deviation (SD) scores for SWEMWBS, PHQ-9 
and GAD-7 were calculated at baseline (assessment) and 
at each subsequent time point. A paired samples T-test 
was used to assess change from baseline to last measure-
ment for participants who completed two, three, four and 
five sessions respectively.
Correlation
Spearman’s Rho was used to assess the correlation 
between the measures at different time points.
SWEMWBS measurement properties
Internal consistency was calculated for SWEMWBS in 
this clinical sample using Cronbach’s Alpha at Time 1 and 
Time 5.
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Time series analysis
Time series analyses were conducted (using General 
Linear Model with Repeated Measures) to assess signifi-
cance of change over time for participants attending two, 
three, four and five sessions respectively across each clin-
ical outcome measure. Within subject effects tests were 
carried out to assess difference of scores over repeated 
sessions, and further within subject contrast tests were 
carried out where data for more than two time points 
were available to identify polynomial contrasts (whether 
the trend was linear, quadratic, cubic or alternate math-
ematical pattern). Corrections were applied where the 
data did not comply with the assumption of sphericity, in 
order to maintain the power of the test and reduce the 
chance of type 2 (false negative) errors. Greenhouse–
geisser corrections were applied when Mauchly’s test 
of sphericity resulted in ε < 0.75 and Huynh Feldt when 
Mauchly’s test of sphericity resulted in ε > 0.75 [43]
Results
Descriptive
The mean age of the participants (N = 127) was 38.0 (95% 
CI 35.4–40.6) years; 74.8% (N = 95) were female and 
96.1% (N = 105) White. The majority were employed, 
lived with a partner and not on medication (Table  1). 
Data was collected on participating therapists and cli-
ents only and the overall consent rate is unknown. For 
86.6% (N = 110) PHQ-9 scores exceeded clinical thresh-
old for depression and for 89.0% (N = 113) of participants 
GAD-7 scores exceeded clinical threshold for anxiety at 
Therapy Session 1. Most participants appeared to have 
a mixed picture of anxiety and depression symptoms, 
82.6% (N = 105) exceeded clinical threshold for both 
scales. For 70.1% (N = 89) SWEMWBS scores were at or 
below the 1 SD cut point for low mental wellbeing of 19.3 
at Therapy session 1.
127 participants attended and provided data at two 
therapy sessions, 94 at three, 63 at four and 34 at five. 
Mean scores are shown in Table  2. Participants who 
attended more than two sessions had slightly lower 
SWEMWBS scores at baseline (five sessions 18.8; four 
sessions 18.6; and three sessions 18.6 cf 19.0 for one ses-
sion only) and higher PHQ-9 (five sessions 13.0; four 
sessions 12.2 and three sessions 12.2 cf 11.5 for one ses-
sion only) and GAD-7 (five sessions 13.1; four sessions 
12.8 and three sessions 12.1 cf 11.6 for one session only) 
scores at baseline, indicating worse states of mental 
health at start of therapy.
GAD-7 and PHQ-9 scores were not normally distrib-
uted or correctable by log transformation at any time 
point. On visual inspection non-normality was accounted 
for by extreme outliers. A non-parametric test, Spear-
man’s Rho was chosen for correlation assessment, allow-
ing assessment of a non-linear relationship. Outliers 
were adjusted by winsorisation [44] in repeated measures 
analysis. SWEMWBS scores were normally distributed 
and no adjustment was applied. Internal consistency 
calculated using Cronbach’s Alpha was 0.887 at Time 1 
(N = 127); and 0.930 at Time 5 (N = 34). Paired samples 
T-Tests indicated that significant changes in scores were 
seen from baseline to last measurement across all three 
measures for participants who completed two, three, four 
and five sessions respectively.
Correlation between measures
Correlations between SWEMWBS and PHQ-9 scores 
were negative and significant (P < 0.005) at each time 
point; coefficients ranged from -0.60 at Therapy 1 to 
−  0.79 at Therapy 5 (Table  3). Correlations between 
Table 1 Demographic characteristics
Demographic characteristic Category, N (%)
Gender Female Male Not specified
95 (74.8%) 28 (22%) 4 (3.1%)
Age 18–29 30–49 50–69 70 + Not specified
22 (17.3%) 63 (49.6%) 19 (15.0%) 2 (1.6%) 6 (4.7%)
Ethnicity White African Indian Mixed‑ethnicity Not specified
105 (96.1%) 1 (0.8%) 6 (4.7%) 1 (0.8%) 14 (11%)
Employment Employed Unemployed
100 (78.7%) 27 (21.3%)
Living arrangements Alone With partner With parents Other shared Not Specified
25 (19%) 81 (63.8%) 15 (11.8%) 5 (3.9%) 1 (0.8%)
Medication Antidepressants Anxiolytics/hypnotics Other None Not specified
17 (13.4%) 2 (1.6%) 5 (3.9%) 99 (78.0%) 4 (3.1%)
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SWEMWBS scores and GAD-7 scores were also nega-
tive and significant (P < 0.005) at each time point with 
coefficients ranging from -0.63 at Therapy 1 to − 0.74 at 
Therapy 5 (Table 2). Slightly higher positive correlations 
were found between the two clinical scales, PHQ-9 and 
GAD-7 (0.73–0.87, P < 0.005).
Time series analyses
Mean SWEMWBS scores increased, and mean PHQ-9 
and GAD-7 scores decreased at each consecutive therapy 
session in all groups. For PHQ-9 and GAD-7, the greatest 
change in scores was seen between Therapy 1 and Ther-
apy 2, and change tapered over time. SWEMWBS change 
scores remained consistent between each time point, 
demonstrating a more linear relationship (see Fig. 1). For 
each participant group (attending two, three, four and 
five sessions respectively) a significant (P < 0.005) change 
was seen between baseline and last measurement on all 
three measures (see Table  4.) For SWEMWBS scores, a 
linear effect was found for participants who completed 
three, four and five consecutive sessions, whereas for 
GAD-7 and PHQ-9 both a linear and a quadratic trend 
was observed in these groups, consistent with the 
observed tapering in scores over time.
Discussion
Summary of findings
SWEMWBS, PHQ-9 and GAD-7 all showed improve-
ments during treatment and for all three scales there 
was evidence of individual improvement meeting cri-
teria for statistical and minimally important change at 
all time points [37, 40, 41]. SWEWMBS scores were 
strongly and inversely correlated with PHQ-9 and 
GAD-7 scores at all time points: correlations were 
stronger at time 5 compared to time 1, increasing with 
Table 2 Mean and standard deviation of scores for SWEMWBS PHQ‑9 and GAD‑7 at all time points
Participants group (N) Time SWEMWBS mean score (SD) PHQ-9 mean score (SD) GAD-7 mean score (SD)
Participants who completed two sessions (N = 127) Therapy 1 19.0 (3.6) 11.5 (6.2) 11.6 (5.4)
Therapy 2 20.4 (4.1) 7.8 (6.2) 8.3 (5.5)
Change 1–2 1.4 (2.9) P < 0.005 − 3.7 (4.7) P < 0.005 − 3.3 (3.8) P < 0.005
Participants who completed three sessions (N = 94) Therapy 1 18.6 (3.6) 12.2 (6.0) 12.1 (5.6)
Therapy 2 20.0 (4.0) 8.4 (5.9) 8.9 (5.6)
Therapy 3 21.6 (5.4) 6.9 (6.0) 7.1 (5.5)
Change 1–3 3.0 (4.4) P < 0.005 − 5.3 (5.9) P < 0.005 − 5.1 (5.2) P < 0.005
Participants who completed four sessions (N = 63) Therapy 1 18.6 (3.7) 12.2 (6.0) 12.8 (5.1)
Therapy 2 19.9 (3.5) 8.5 (5.7) 9.1 (5.5)
Therapy 3 21.2 (4.3) 7.1 (5.7) 7.3 (5.4)
Therapy 4 22.3 (4.4) 6.1 (5.0) 6.5 (5.1)
Change 1–4 3.7 (4.2) P < 0.005 − 5.9 (5.8) P < 0.005 − 6.1 (5.3) P < 0.005
Participants who completed five sessions (N = 34) Therapy 1 18.8 (3.5) 13.0 (6.6) 13.1 (4.9)
Therapy 2 20.2 (4.1) 8.8 (6.7) 9.2 (5.5)
Therapy 3 21.7 (4.3) 7.2 (6.2) 7.5 (5.4)
Therapy 4 22.2 (4.0) 6.6 (5.1) 6.6 (5.1)
Therapy 5 23.4 (5.0) 6.3 (6.3) 6.1 (5.4)
Change 1–5 4.6 (4.4) P < 0.005 − 6.7 (6.3) P < 0.005 − 7.0 (5.9) P < 0.005
Table 3 Correlation of scores on SWEMWBS, PHQ‑9 and GAD‑7 
at all time points




SWEMWBS and PHQ‑9 Therapy 1 127 − 0.60 < 0.005
Therapy 2 127 − 0.72 < 0.005
Therapy 3 94 − 0.67 < 0.005
Therapy 4 63 − 0.73 < 0.005
Therapy 5 34 − 0.79 < 0.005
SWEMWBS and GAD‑7 Therapy 1 127 − 0.63 < 0.005
Therapy 2 127 − 0.63 < 0.005
Therapy 3 94 − 0.65 < 0.005
Therapy 4 64 − 0.73 < 0.005
Therapy 5 34 − 0.74 < 0.005
PHQ‑9 and GAD‑7 Therapy 1 127 0.73 < 0.005
Therapy 2 127 0.81 < 0.005
Therapy 3 94 0.83 < 0.005
Therapy 4 64 0.82 < 0.005
Therapy 5 34 0.87 < 0.005
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each measurement point (Table 3). The increasing cor-
relations between therapy sessions 1 and 5 suggest that 
the scales become more convergent as mental health 
improves for patients. It is not clear why correlations 
increase: one explanation is that repeated completion of 
all measures may lead to greater accuracy in recording, 
a second could be that therapeutic intervention leads to 
greater self-awareness and thus more precision in com-
pletion of measures.
PHQ-9 and GAD-7 scores improved in a curvilinear 
way with evidence of a quadratic trend in change over 
time, greatest improvement was seen between Therapy 
1 and Therapy 2. SWEMWBS scores also improved but 
the trend was linear (Table  4). Score distributions on 
SWEMWBS, but not PHQ-9 or GAD-7 were normally 
distributed.
The tapering in change scores as participants improved 
seen with the clinical measures was not evident with 
SWEMWBS. Results suggest that the two clinical meas-
ures show greater change at the lower (less well) end of 
the mental health spectrum and SWEMWBS may be 
more sensitive to change at the less unwell end of the 
spectrum. Differences in the trend of change over time 
for SWEMWBS and clinical measures and correlation at 
less than 0.9 at different time points could be due to dif-
ferences in the measurement properties of the different 
scales, particularly ceiling effects with the mental illness 
measures. This suggestive finding needs corroborating in 
other studies; if it proves valid it would be consistent with 
the intended purposes of the different scales.
Implications and comparison to other literature
These results suggest that SWEMWBS shows construct 
validity as a clinical outcome measure for patients with 
CMD and can be used to assess change over multiple 
time points. This, together with patients’ preference for 
positively focused measures [13], makes SWEMWBS a 
candidate for evaluating psychological interventions in 
this setting.
Our findings align with those of a sample of clinical 
patients with Severe Mental Illness undergoing psycho-
logical therapy, where change with similar effect size was 
seen using WEMWBS when compared to clinical meas-
ures [24, 25]. A pilot of a mental health support service 
for doctors in the UK also found change across both clin-
ical measures and WEMWBS before and after treatment, 
with a greater effect size seen with WEMWBS, Perceived 
Stress Scale and Psychological Outcome Profiles (Psy-
chlops) than with PHQ-9 or GAD-7 [45]. This positive 
focus complements and supports positive psychology 
and asset-based approaches.
SWEMWBS could be considered either on its own or 
in conjunction with clinical measures, which may pro-
vide greater sensitivity at the onset of intervention when 
patients have worse levels of mental health. The lack of 
tapering suggests that SWEMWBS enables measure-
ment beyond clinical cut-off points for CMD and thus 
meets the need for a measure that is appropriate and 
valid across public health and clinical interventions. The 
respective sensitivity of the scales at higher levels of men-
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investigated in future research. Given the small sample 
size and limited diversity of the sample, the findings in 
this study should be further investigated in larger data-
sets such as in the NHS where SWEMWBS and WEM-
WBS are both being used in clinical populations [23]
A recent population-based psychometric analysis [19] 
of WEMWBS items and items in the psychological dis-
tress measure GHQ -12 suggested both scales measure 
a single dimension or underlying construct. We did not 
a-priori specify what level of correlation would be suffi-
cient to prove or disprove the dual continuum model for 
SWEMWBS in comparison to the PHQ-9 and GAD-7 
measures of depression and anxiety. Correlations over 
0.5 have been hypothesised to show adequate conver-
gent validity [46] in patient reported outcome measures. 
In a true dual continuum model correlations would be 
expected to approach 0. The correlations (all > 0.6) we 
observed in this study suggest at least partial if not full 
overlap between the constructs.
Strengths and limitations
Few studies collect data using both positive and negative 
outcome measures over multiple time points to allow the 
comparisons made in this study, but the relatively small 
sample, consisting of mainly white women who were able 
to pay fees for private therapy, limits conclusions with 
regard to the changes which might be observed in a more 
diverse and wider population. Although there is no a pri-
ori reason to suppose that the relationship between these 
scales would be different in different population groups, 
conclusions drawn would be strengthened by validation 
in other populations.
Within this cohort the majority of participants com-
pleted two sessions. The number of participants with 
analysable data reduced with each consecutive session. In 
46.5% of instances this represented documented planned 
endings and in others the ending may have been mutually 
agreed given the nature of the practice. Nonetheless, the 
possibility remains that the groups completing up to five 
sessions may have differed to those completing fewer ses-
sions: those who were motivated to attend more sessions 
may have had a greater capacity to reach higher levels of 
wellbeing; or those who were not experiencing benefit 
may have terminated sessions earlier. These limitations 
would be important if the data were being used to evalu-
ate the effectiveness of CHT, but this was not the purpose 
of this study. They do not impact the validity of conclu-
sions relating to the measurement properties of the three 
scales.
Reflection on scores of all three scales during ther-
apy sessions may have introduced social desirability 
bias but there is no a priori reason to believe that this 
would have affected responses to the three measures 
differentially.
Conclusions
In this exploratory analysis, SWEMWBS demonstrates 
construct validity and sensitivity to change as a clinical 
outcome measure for patients with CMDs in primary 
care, demonstrating inverse correlation and comparable 
sensitivity to change over a course of clinical treatment 
when compared to two widely used clinical outcome 
measures. These analyses provide support for the use of 
SWEMWBS use as an outcome measure for clinicians 
and services who wish to respect clients’ preference for 
SWEMWBS over negative and illness focused measures 
[18]. Results are compatible with SWEMWBS’ potential 
as an outcome measure that is valid across clinical and 
Table 4 Repeated Measures Analyses (GLM repeated measures) of change over time
* Greenhouse Geisser correction applied
** Huynh Feldt Correction applied
Total number of sessions completed was also fitted for each time point but this did not have a significant effect at any time point
Participant group (N) Test SWEMWBS F statistic 
(P-value)
GAD7 F statistic (P-value) PHQ9 F statistic (P-value)
Participants who completed 
two sessions (N = 127)
Within subject effects 31.760 (< 0.005) 97.205 (< 0.005) 71.041 (< 0.005)
Participants who completed 
three sessions (N = 94)
Within subject effects 34.094 (< 0.005)* 67.809 (< 0.005)* 54.272 (< 0.005)**
Within subject contrasts Linear 45.137 (< 0.005)
Quadratic 0.156 (0.690)
Linear 94.756 (< 0.005)
Quadratic 6.132 (0.015)**
Linear 76.334 (< 0.005)
Quadratic 8.886 (0.004)
Participants who completed 
four sessions (N = 63)
Within subject effects 33.433 (< 0.005)* 49.312 (< 0.005)** 39.225 (< 0.005)**
Within subject contrasts Linear 51.434 (< 0.005)
Quadratic 0.234 (0.634)
Linear 83.358 (< 0.005)
Quadratic 10.152 (0.002)
Linear 67.198 (< 0.005)
Quadratic 11.511 (0.001)
Participants who completed five 
sessions (N = 34)
Within subject effects 20.294 (< 0.005)* 27.001 (< 0.005)* 19.368 (< 0.005)**
Within subject contrasts Linear 38.196 (< 0.005)
Quadratic 1.949 (0.172)
Linear 45.44 (< 0.005)
Quadratic 25.477 (< 0.005)
Linear 31.234 (< 0.005)
Quadratic 21.702 (< 0.005)
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public health settings from treatment to recovery. Given 
patient preference for positively over negatively framed 
measures and statistical advantages of measures that 
are normally distributed, SWEMWBS could be used as 
an alternative to PHQ-9 and GAD-7 in monitoring and 
evaluation of CMD treatment. Confirmation of results 
with larger samples and diverse populations would be 
valuable.
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